Bill Text: NY A00197 | 2023-2024 | General Assembly | Introduced


Bill Title: Relates to synthetic cannabinoids, synthetic cannabinoid analog and substituted cathinones; prohibits the production and sale thereof.

Spectrum: Moderate Partisan Bill (Democrat 7-1)

Status: (Introduced) 2024-01-03 - referred to health [A00197 Detail]

Download: New_York-2023-A00197-Introduced.html



                STATE OF NEW YORK
        ________________________________________________________________________

                                           197

                               2023-2024 Regular Sessions

                   IN ASSEMBLY

                                       (Prefiled)

                                     January 4, 2023
                                       ___________

        Introduced by M. of A. MAGNARELLI, BARCLAY, COOK, SIMON, PEOPLES-STOKES,
          OTIS,  WOERNER, JEAN-PIERRE -- read once and referred to the Committee
          on Health

        AN ACT to amend the public health law, the penal  law  and  the  general
          business  law, in relation to synthetic cannabinoids, synthetic canna-
          binoid  analog  and  substituted  cathinones   and   prohibiting   the
          production and sale thereof

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Section 3302 of the public health law is amended by  adding
     2  three new subdivisions 42, 43 and 44 to read as follows:
     3    42. "Synthetic cannabinoid" means any chemical compound that is chemi-
     4  cally synthesized and:
     5    (a)  has  been  demonstrated to have a binding activity at one or more
     6  cannabinoid receptors; or
     7    (b) is a chemical isomer, salt or salt of an isomer of a compound that
     8  has been demonstrated to have binding activity at one or  more  cannabi-
     9  noid receptors; or
    10    (c)  has  been designated in regulation by the commissioner as being a
    11  synthetic cannabinoid or synthetic cannabinoid analog.
    12    "Synthetic cannabinoid" does not include any  product  that  has  been
    13  approved  for  medical  use  by the United States Food and Drug Adminis-
    14  tration.
    15    43. "Synthetic cannabinoid analog" means any chemical that is substan-
    16  tially similar in chemical structure to a  chemical  compound  that  has
    17  been  determined  to  have  binding  activity at one or more cannabinoid
    18  receptors. It does not include any products that have been approved  for
    19  medical use by the United States Food and Drug Administration.
    20    44. "Substituted cathinone" means any chemical compound that is chemi-
    21  cally synthesized and:

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD00279-01-3

        A. 197                              2

     1    (a)  is a compound listed in paragraph five, eight or nine of subdivi-
     2  sion (f) of schedule I of section thirty-three hundred six of this arti-
     3  cle, or
     4    (b)  has been designated in regulation by the commissioner as having a
     5  chemical structure derivative of cathinone, or
     6    (c) any compound, other than buproprion, that is structurally  derived
     7  from  2-amino-1-phenyl-1-propanone by modification in any of the follow-
     8  ing ways:
     9    (i) by substitution in the phenyl  ring  to  any  extent  with  alkyl,
    10  alkoxy, alkylenedioxy, haloalkyl, or halide substituents, whether or not
    11  further  substituted  in  the phenyl ring by one or more other univalent
    12  substituents;
    13    (ii) by substitution at the three-position with an alkyl substitutent;
    14    (iii) by substitution at the  nitrogen  atom  with  alkyl  or  dialkyl
    15  groups, or by inclusion of the nitrogen atom in a cyclic structure.
    16    §  2.  Subdivision 5 of section 220.00 of the penal law, as amended by
    17  chapter 92 of the laws of 2021, is amended to read as follows:
    18    5. "Controlled substance" means any substance listed  in  schedule  I,
    19  II,  III,  IV  or  V  of  section thirty-three hundred six of the public
    20  health law, and  substituted  cathinones as defined in  section  thirty-
    21  three hundred two of the public health law.
    22    §  3. The general business law is amended by adding a new section 399-
    23  jj to read as follows:
    24    § 399-jj. Sale of synthetic cannabinoid, synthetic cannabinoid  analog
    25  and  substituted  cathinone prohibited. 1. For purposes of this section,
    26  "synthetic cannabinoid"  means  any  substance  defined  by  subdivision
    27  forty-two  or  forty-three  of  section  thirty-three hundred two of the
    28  public health  law  and  "substituted  cathinone"  means  any  substance
    29  defined by subdivision forty-four of section thirty-three hundred two of
    30  the public health law.
    31    2.  No  person,  corporation, partnership or limited liability company
    32  shall knowingly sell or offer for sale any form  of  synthetic  cannabi-
    33  noid, substituted cathinone or any other substance intended to act as or
    34  advertised  as an alternative form of a controlled substance. No person,
    35  corporation, partnership or limited liability company  shall  offer  any
    36  substance  for  sale  where  there has been an explicit or implied claim
    37  made by the selling party that the substance sold will mimic or approxi-
    38  mate the same effects of cannabinoid, synthetic cannabinoid, substituted
    39  cathinone or any other substance intended to act as or advertised as  an
    40  alternative form of a controlled substance.
    41    3.  Whether  a violation of this section has occurred is a question of
    42  law for the court.
    43    4. Whenever there shall be a violation of this section an  application
    44  may  be  made  by  the attorney general in the name of the people of the
    45  state of New York to a court or justice having jurisdiction by a special
    46  proceeding to issue an injunction, and upon notice to the  defendant  of
    47  not  less than five days, to enjoin and restrain the continuance of such
    48  violation; and if it shall appear to the satisfaction of  the  court  or
    49  justice  that  the  defendant  has,  in  fact, violated this section, an
    50  injunction may  be  issued  by  the  court  or  justice,  enjoining  and
    51  restraining  any  further  violations,  without requiring proof that any
    52  person has, in fact, been  injured  or  damaged  thereby.  In  any  such
    53  proceeding  the  court  may  make  allowances to the attorney general as
    54  provided in paragraph six of subdivision  (a)  of  section  eighty-three
    55  hundred  three  of the civil practice law and rules, and direct restitu-
    56  tion. A violation of the provisions of this section shall be an  offense

        A. 197                              3

     1  punishable  by  a  penalty  of  five  thousand dollars for each separate
     2  violation. A violation of the provisions of this  section  after  having
     3  been  previously  convicted  of such an offense within the previous five
     4  years  shall  be a class A misdemeanor punishable by a fine of ten thou-
     5  sand dollars for each separate violation. The  penalties  for  any  such
     6  violation should include such an illegal sale that having been made to a
     7  person under the age of eighteen shall be a class E felony as defined in
     8  the penal law.
     9    § 4. This act shall take effect immediately.
feedback